Shivinder Singh's petition against brother Malvinder and former Religare CEO Sunil Godhwani points at only the tip of the iceberg in the corporate mismanagement that led to the Singh brothers losing control of Fortis Healthcare and  Religare.

Shobana Kamineni has been the key force behind growth in the pharmacy and insurance business for Apollo.

How Malvinder and Shivinder Singh blew Rs 22,500 crore in less than a decade and lost control over Fortis Healthcare and Religare Enterprises.

Atal Bihari Vajpayee passed away today at the age of 93. Leaders cutting across the political spectrum mourned the loss of India's former prime minister.

India's $160 billion healthcare ecosystem is undergoing unprecedented shift.

Ayushman Bharat can do to healthcare what GST is expected to do to India's indirect tax regime. But there are challenges, too.

Most leading hospitals are struggling to make profits. At the same time, new formats, specialties and technology assisted ventures are coming up with a promise of transforming the sector.

The head honchos of some of the leading hospitals seem willing to work with the government, but are seeking rates that are \"at least in line with what is being offered under the CGHS\".

The US FDA recently gave green signal to market IDx-DR, a medical device to detect diabetic retinopathy, a disease in which high blood sugar damages blood vessels in the retina of eyes and leads to the vision loss.

The bidding war has raised the value of each Fortis share nearly 50% from the lowest offer of Rs 126 per share to Rs 185 per share. So what makes Fortis so valuable?

Though mired in promoter issues and complex management holding structures in the past, there are many factors that make Fortis a 'must chase' target for leading domestic and international chains, say experts in the healthcare industry.

Fortis Healthcare Ltd has received as many as five offers for control of its private hospital business, but suitors have so far held back from making bold bids for the group as it faces rising debt and a regulatory probe.

The race to acquire Fortis is heating up. Fortis Healthcare Ltd (FHL) on Thursday said it has received a revised offer from Munjal-owned Hero Enterprise Investment Office and Burman Family Office.

Shareholders of Fortis Healthcare Ltd (FHL) finally have cause to celebrate, with Manipal Health Enterprises (MHEPL) upping the merger offer on the table by 21 per cent. The revised proposal values the hospital business of FHL at Rs 6,061 crore, which is Rs 1,058 crore more than its equity valuation.

Speaking to Business Today, he spells out his vision, immediate priorities, the time that the deal will take to conclude and how the new entity has been ring-fenced from any of the investigations by SEBI and the SFIO, mostly related to its erstwhile promoters.

Choosing health insurance plans can get complicated and a lot can go wrong, which is why you must make an informed choice.